Bernd Kieseier: Review of teriflunomide and its potential in the treatment of multiple sclerosis. In: Neuropsychiatric Disease and Treatment. S. 333, doi:10.2147/NDT.S4474. PMID 19557143.
europa.eu
ema.europa.eu
Aubagio - teriflunomide. Summary of the European public assessment report (EPAR) for Aubagio; abgerufen am 5. Februar 2014.
P. L. van Riel, J. S. Smolen, P. Emery, J. R. Kalden, M. Dougados: Leflunomide: a manageable safety profile. In: J Rheumatol Suppl., 71, Jun 2004, S. 21–24. PMID 15170904.
M. Takeishi, Y. Akiyama, H. Akiba, D. Adachi, M. Hirano: Leflunomide induced acute interstitial pneumonia. In: J Rheumatol. 32(6), Jun 2005, S. 1160–1163. PMID 15940779.
Bernd Kieseier: Review of teriflunomide and its potential in the treatment of multiple sclerosis. In: Neuropsychiatric Disease and Treatment. S. 333, doi:10.2147/NDT.S4474. PMID 19557143.
R. R. Bartlett, R. Schleyerbach: Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity – I. Disease modifying action on adjuvant arthritis of the rat. In: Int J Immunopharmacol., 7, 1985, S. 7–18. PMID 3873420.